Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Immune Response Resetting in Ongoing Sepsis.

Nowill AE, Fornazin MC, Spago MC, Dorgan Neto V, Pinheiro VRP, Alexandre SSS, Moraes EO, Souza GHMF, Eberlin MN, Marques LA, Meurer EC, Franchi GC Jr, de Campos-Lima PO.

J Immunol. 2019 Sep 1;203(5):1298-1312. doi: 10.4049/jimmunol.1900104. Epub 2019 Jul 29.

2.

CAR T Cells Generated Using Sleeping Beauty Transposon Vectors and Expanded with an EBV-Transformed Lymphoblastoid Cell Line Display Antitumor Activity In Vitro and In Vivo.

Chicaybam L, Abdo L, Carneiro M, Peixoto B, Viegas M, de Sousa P, Fornazin MC, Spago MC, Albertoni Laranjeira AB, de Campos-Lima PO, Nowill A, Barros LRC, Bonamino MH.

Hum Gene Ther. 2019 Apr;30(4):511-522. doi: 10.1089/hum.2018.218.

PMID:
30793967
3.

Low Bioavailability and High Immunogenicity of a New Brand of E. colil-Asparaginase with Active Host Contaminating Proteins.

Zenatti PP, Migita NA, Cury NM, Mendes-Silva RA, Gozzo FC, de Campos-Lima PO, Yunes JA, Brandalise SR.

EBioMedicine. 2018 Apr;30:158-166. doi: 10.1016/j.ebiom.2018.03.005. Epub 2018 Mar 9.

4.

Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis.

Brandalise SR, Assis R, Laranjeira ABA, Yunes JA, de Campos-Lima PO.

Exp Hematol Oncol. 2017 Jun 19;6:18. doi: 10.1186/s40164-017-0078-1. eCollection 2017.

5.

The size of the unbranched aliphatic chain determines the immunomodulatory potency of short and long chain n-alkanols.

Carignan D, Désy O, Ghani K, Caruso M, de Campos-Lima PO.

J Biol Chem. 2013 Aug 23;288(34):24948-55. doi: 10.1074/jbc.M113.466334. Epub 2013 Jul 9.

6.

Nilotinib and imatinib inhibit cytarabine cellular uptake: implications for combination therapy.

Naud JS, Ghani K, de Campos-Lima PO, Caruso M.

Leuk Res. 2012 Oct;36(10):1311-4. doi: 10.1016/j.leukres.2012.06.012. Epub 2012 Jul 12.

PMID:
22796208
7.

Short-term immunological effects of non-ethanolic short-chain alcohols.

Désy O, Carignan D, de Campos-Lima PO.

Toxicol Lett. 2012 Apr 5;210(1):44-52. doi: 10.1016/j.toxlet.2012.01.005. Epub 2012 Jan 13. Review.

PMID:
22266471
8.
9.

The idiotype (Id) cascade in mice elicited the production of anti-R24 Id and anti-anti-Id monoclonal antibodies with antitumor and protective activity against human melanoma.

Ramos AS, Parise CB, Travassos LR, Han SW, de Campos-Lima PO, de Moraes JZ.

Cancer Sci. 2011 Jan;102(1):64-70. doi: 10.1111/j.1349-7006.2010.01771.x. Epub 2010 Nov 10.

10.

Methanol induces a discrete transcriptional dysregulation that leads to cytokine overproduction in activated lymphocytes.

Désy O, Carignan D, Caruso M, de Campos-Lima PO.

Toxicol Sci. 2010 Oct;117(2):303-13. doi: 10.1093/toxsci/kfq212. Epub 2010 Jul 8.

PMID:
20616203
11.

Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy.

Cottin S, Ghani K, de Campos-Lima PO, Caruso M.

Mol Cancer. 2010 Jun 10;9:141. doi: 10.1186/1476-4598-9-141.

12.

Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery.

Ghani K, Cottin S, de Campos-Lima PO, Caron MC, Caruso M.

J Gene Med. 2009 Aug;11(8):664-9. doi: 10.1002/jgm.1351.

PMID:
19507185
13.

Efficient human hematopoietic cell transduction using RD114- and GALV-pseudotyped retroviral vectors produced in suspension and serum-free media.

Ghani K, Wang X, de Campos-Lima PO, Olszewska M, Kamen A, Rivière I, Caruso M.

Hum Gene Ther. 2009 Sep;20(9):966-74. doi: 10.1089/hum.2009.001.

15.

Rescue of the immunotherapeutic potential of a novel T cell epitope in the Epstein-Barr virus latent membrane protein 2.

Lalonde A, Avila-Cariño J, Caruso M, de Campos-Lima PO.

Virology. 2007 May 10;361(2):253-62. Epub 2007 Jan 4.

16.
17.
18.

Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.

Dolcetti R, Frisan T, Sjöberg J, De Campos-Lima PO, Pisa P, De Re V, Gloghini A, Rizzo S, Masucci MG, Boiocchi M.

Cancer Res. 1995 Aug 15;55(16):3675-81.

19.

Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma.

Imreh MP, Zhang QJ, de Campos-Lima PO, Imreh S, Krausa P, Browning M, Klein G, Masucci MG.

Int J Cancer. 1995 Jul 4;62(1):90-6.

PMID:
7601573
20.
21.

Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.

Wendel-Hansen V, Sällström J, De Campos-Lima PO, Kjellström G, Sandlund A, Siegbahn A, Carlsson M, Nilsson K, Rosén A.

Leukemia. 1994 Mar;8(3):476-84.

PMID:
8127151
22.

Transformation-associated Epstein-Barr virus antigens as targets for immune attack.

Masucci MG, Gavioli R, de Campos-Lima PO, Zhang QJ, Trivedi P, Dolcetti R.

Ann N Y Acad Sci. 1993 Aug 12;690:86-100. Review. No abstract available.

PMID:
7690218
23.

Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.

Trivedi P, Cuomo L, de Campos-Lima PO, Imreh MP, Kvarnung K, Klein G, Masucci MG.

J Gen Virol. 1993 Jul;74 ( Pt 7):1393-8.

PMID:
8393080
24.

HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population.

de Campos-Lima PO, Gavioli R, Zhang QJ, Wallace LE, Dolcetti R, Rowe M, Rickinson AB, Masucci MG.

Science. 1993 Apr 2;260(5104):98-100.

PMID:
7682013
25.

Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.

Cuomo L, Trivedi P, de Campos-Lima PO, Zhang QJ, Ragnar E, Klein G, Masucci MG.

Mol Immunol. 1993 Apr;30(5):441-50.

PMID:
7681932
26.

Antigen processing and presentation by EBV-carrying cell lines: cell-phenotype dependence and influence of the EBV-encoded LMP1.

de Campos-Lima PO, Torsteinsdóttir S, Cuomo L, Klein G, Sulitzeanu D, Masucci MG.

Int J Cancer. 1993 Mar 12;53(5):856-62.

PMID:
8383631
27.

Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.

Gavioli R, Kurilla MG, de Campos-Lima PO, Wallace LE, Dolcetti R, Murray RJ, Rickinson AB, Masucci MG.

J Virol. 1993 Mar;67(3):1572-8.

28.

Human papillomavirus genomes in male urethral cells.

Della Torre G, Donghi R, de Campos Lima PO, Pasquini G, Pilotti S, Koronel R, Pierotti MA, De Palo G, Della Porta G, Rilke F.

Am J Pathol. 1992 Nov;141(5):1181-6.

29.

Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.

Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB.

Int Immunol. 1992 Nov;4(11):1283-92.

PMID:
1282031
30.

Supplemental Content

Loading ...
Support Center